30/12/2025
📊 Dissemination Event | Turning Evidence into Action on AMR in Pakistan
Stakeholders convened in Islamabad for the Dissemination Event on Pakistan Antimicrobial Consumption Analysis (2022–2024) and the Burden of Disease of Healthcare-Associated Infections (HAIs)—bringing critical evidence to the forefront of Pakistan’s AMR response.
🔍 Key insights shared
High and often inappropriate antimicrobial use continues to drive resistance across healthcare settings.
Healthcare-associated infections significantly increase patient morbidity, mortality, and healthcare costs.
Gaps in routine surveillance and standardized reporting limit timely, evidence-based decision-making.
📌 Key recommendations highlighted
Strengthen antimicrobial stewardship programmes across public and private healthcare facilities.
Institutionalize routine AMR, AMC, and HAI surveillance to guide policy and clinical practice.
Enhance infection prevention and control (IPC) measures to reduce preventable infections and antimicrobial use.
Promote multisectoral coordination under the One Health approach to ensure sustainable impact.
The discussions reinforced the importance of translating data into policy action to safeguard patient safety and protect the effectiveness of life-saving antimicrobials.